IL-32 appears to play an important role in pathophysiologic states associated with dysregulated inflammatory responses, including rheumatoid arthritis, chronic obstructive pulmonary disease, psoriasis, and inflammatory bowel disease [13,18,32]. The gene discussed is IL32; the disease is inflammatory bowel disease.